AA
AlphaCentric Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $275K | Sell |
7,123
-17,877
| -72% | -$690K | 0.27% | 92 |
|
2024
Q3 | $1.13M | Hold |
25,000
| – | – | 0.84% | 42 |
|
2024
Q2 | $866K | Hold |
25,000
| – | – | 0.64% | 56 |
|
2024
Q1 | $723K | Sell |
25,000
-5,000
| -17% | -$145K | 0.44% | 75 |
|
2023
Q4 | $688K | Sell |
30,000
-13,500
| -31% | -$310K | 0.46% | 64 |
|
2023
Q3 | $726K | Buy |
+43,500
| New | +$726K | 0.41% | 77 |
|